Company intelligence / Profile preview

Chrysalis Pharma

Overview

No clinical results or pipeline data available. The company appears to be focused on pharmaceutical manufacturing rather than drug development.

1 asset

Phase 1

Indications: Acute respiratory distress syndrome, Brain cancer, Nuclear radiation exposure, Traumatic brain injury

Beyond the preview

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Follow clinical development from trial design and recruitment through results.

Explore licensing agreements, acquisitions, and the assets behind each deal.

Trace financing activity and the investors behind a company’s development.

Compare peer pipelines by target, modality, and therapeutic area.

Explore technology platforms and the patent landscape around relevant assets.

Connect company news and source material to the questions you’re investigating.

See how Gosset can support your research on Chrysalis Pharma.